New shot targets hepatitis b cure in Asia-Pacific trial
NCT ID NCT07370207
Summary
This study is testing whether an experimental injection called AHB-137 can help control chronic hepatitis B in people already taking standard antiviral medications. Researchers will give the injection to 84 adults in Asia Pacific who have a specific type of hepatitis B and measure whether it reduces virus levels enough to potentially stop all treatment. The main goal is to see if participants achieve very low or undetectable virus levels after receiving AHB-137.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Chiayi Christian Hospital
Chiayi City, 60002, Taiwan
-
E-DA Hospital
Kaohsiung City, 82445, Taiwan
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
National University Hospital - Singapore
Singapore, 119074, Singapore
-
New Zealand Clinical Research
Grafton, Auckland, 1010, New Zealand
-
Queen Mary Hospital - PPDS
Hong Kong, China
-
St Vincents Hospital Melbourne
Fitzroy, Victoria, 3065, Australia
Conditions
Explore the condition pages connected to this study.